L.E.A.F. Pharmaceuticals Email Formats
Pharmaceutical Manufacturing • 
United States • 1-10 Employees
L.E.A.F. Pharmaceuticals Email Formats
L.E.A.F. Pharmaceuticals uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@leafpharmaceuticals.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@leafpharmaceuticals.com | 100% |
Key Contact at L.E.A.F. Pharmaceuticals
Clet Niyikiza
President
Company overview
| Headquarters | United States |
| Phone number | +17813054192 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Founded | 2014 |
| Employees | 1-10 |
| Socials |
About L.E.A.F. Pharmaceuticals
4 new pre-clinical stage antifolates candidates, all much more potent than Alimta®, an existing lung cancer drug with $34billion cumulative revenues before its loss of exclusivity in May 2022. The lead drug has FDA and EMA agreements for expedited NDA/marketing approval via 505(b)(2) application pathway to replace Alimta® in lung cancer treatment regimen.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
L.E.A.F. Pharmaceuticals has never raised funding before.
France
Australia
Belgium
Frequently asked questions
4.8
40,000 users
